Revised April 2020

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

April 2020 revision covers:

• Additional information on the USDA Interim Final Rule issued in October 2019
• USDA updates since then, including two portions of the interim final rule for which they will be implementing enforcement discretion
• What growers should be aware of for the 2020 growing season
• FDA developments since the report was last issued – warning letters continue to be issued, the consumer update issued in October 2019,
• March 2020 FDA report to Congress on CBD regulation, and consideration of legislative options

The revised Status Report: Marketing of hemp and cannabidiol (CBD) products in the United States following passage of the 2018 Farm Bill also covers:

• FDA actions on hemp-derived CBD in dietary supplements and foods, including recent public statements, hearings, enforcement policy and safety review.
• FDA’s position on hemp-CBD in cosmetics as stated on its website Q&A.
• USDA’s listening session to gather information and feedback from stakeholders as they develop regulations.
• Details on USDA's Hemp Production Program to be administered under the Agricultural Marketing Service (AMS) have been posted on the USDA website.
• USDA has issued a notice to trade regarding the importation of hemp seed.
• USDA issued legal opinions regarding the implementation of some hemp provisions in the 2018 Farm Bill.

Order the updated Status Report here >>